Shareholders approved the move at the AGM and special meeting of shareholders on May 14
Showing 25 of 234
The pot materials will be used in PreveCeutical's soluble gel (Sol-gel) drug delivery research...
The conference takes place at the Encore Hotel in Las Vegas from May 15-17
Dr Piotr Witkowski is a widely published diabetes researcher and respected surgeon
The Colorado biotech drew a US$13 price target from analyst Leah Rush Cann
The company recently made three additional US patent applications and one international patent application
The permits were issued to the Pharmacy Australia Centre of Excellence (PACE) at the University of Queensland which allows PACE to import shipments of cannabis material for research purposes
The equipment delivered will be used to convert raw flaxseed oil into oils with qualities unavailable from standard flaxseed ingredients
The health sciences company has also amended and increased a credit facility agreement with Kimberly Van Deventer and CEO and current president Stephen Van Deventer
The company's Australian JV partner recently entered into a binding MoU with Burleigh Heads Cannabis, which holds an import licence issued by the Australian Office of Drug Control
The company exhibited at the 20th annual Canadian Society of Echocardiography conference
The company has signed partnership agreements with two undisclosed California companies to market and sell its CannaMint strips
Receipts will provide funding for additional four months
The cannabis company may branch out to other states when federal law allows
It means the group is now an integrated antibody solutions company focused on the next generation of technology
CEO says company is poised for growth following a two-year worldwide co-marketing and distribution deal with ISS Inc.
Interim CEO Brian Keane told investors he welcomed the chance to assist in the transition of the company.
RepliCel Life Sciences, the regenerative medicine specialist focused on cell therapies, said first injections had been completed in the phase 1 clinical study evaluating its skin rejuvenation product.
Mackie recommends buying the shares of Patient Home Monitoring ahead of forthcoming full year results.
Third quarter results were largely academic, as the pre-revenue company is still in a transitional stage.
The company intends to use the net proceeds of the offering to build five first-in-human units of its SPORT Surgical System
The deal covers Antibe's anti-inflammatory and pain drugs in Canada, Israel, Romania, Russia and sub-Saharan Africa.
Controversial pharmacy chain to shut down operations as soon as possible
The drug firm is boosted by strong U.S. dermatology business
M Pharmaceutical, a clinical-stage company, responded to merger rumours by confirming it has been in discussions with various third parties concerning the possible acquisition of additional lines of intellectual property by way of license or different forms of business combinations.